Assessing the Medicare Drug Program’s First Decade

The Medicare Part D program, shepherded through Congress by President George W. Bush, turned 10 this year. The program has given more than 23 million U.S. retirees federally supported access to private coverage for prescription drugs. After a decade of experience, what do we know about Part D’s impact on health outcomes, public spending and pharmaceutical innovation?

In a new report for the Progressive Policy Institute (PPI), economist Robert Shapiro provides a comprehensive answer to these questions based on a review of authoritative studies and his own calculations. Please join us Wednesday, December 7, at the National Press Club for release of The Value of the Medicare Part D Program for its Beneficiaries and the Medicare System and a roundtable discussion with Shapiro and other leading health care experts.

The panel, moderated by Susan Dentzer, President and Chief Executive Officer of the Network for Excellence in Health Innovation, also will feature Jack Hoadley, health policy analyst and research professor at Georgetown University’s Health Policy Institute, Doug Badger, senior fellow at the Galen institute, and Leigh Purvis, senior strategic policy advisor with the AARP Public Policy Institute.

Wednesday, December 7, 2016
9:30 am to 11:00 am

National Press Club
Murrow, White, and Lisagor Rooms
529 14th St NW
Washington, D.C. 20045

Registration and light breakfast begin at 9:00 am

Featuring:

Rob Shapiro, Sonecon LLC & Georgetown University
Susan Dentzer, NEHI
Leigh Purvis, AARP
Jack Hoadley, Georgetown University
Doug Badger, Galen Institute

RSVP

Date/Time

12.7.2016
9:00 am - 11:00 am

Location

National Press Club
529 14th St. NW
Washington

Loading Map....